Literature DB >> 32934819

Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review).

Olga V Zhukova1, Tatiana F Kovaleva2, Evgenia V Arkhipova3, Sergey A Ryabov4, Irina V Mukhina5.   

Abstract

The aim of the present study was to evaluate the current body of knowledge regarding tumor-associated macrophages (TAMs) and their potential use in antitumor therapy, based on their role in the pathological process of tumorigenesis. For this purpose, a critical analysis of published data and summarization of the findings available from original studies, focusing on the role of TAMs in the pathological process, and their potential therapeutic application was performed. Promising key avenues of research were identified in this field. The following issues seem the most promising and thus worth further investigation: i) The process of M1/M2 macrophage polarization, macrophage characteristics at intermediate polarization steps and their role in the tumor process; ii) determining the conditions necessary for transitions between the M1 and M2 macrophage phenotypes and the role of signals from the microenvironment in this process; iii) cause-and-effect associations between the quantity and quality of macrophages, and the prognosis and outcome of the pathological process; iv) modulation of macrophages and stimulation of their phagocytic activity with drugs; v) targeted vector-based systems for drug delivery to macrophages; and vi) targeted drug delivery systems with macrophages as carriers, thus potentially combining chemotherapy and immunotherapy.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  M1/M2 polarization; chemotherapy; immunotherapy; macrophages; targeted drug delivery systems; tumor microenvironment; tumor-associated macrophages

Year:  2020        PMID: 32934819      PMCID: PMC7469560          DOI: 10.3892/br.2020.1354

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  128 in total

1.  Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages.

Authors:  Qingshan Wang; Hong Ni; Lan Lan; Xiaoli Wei; Rong Xiang; Yue Wang
Journal:  Cell Res       Date:  2010-04-13       Impact factor: 25.617

2.  Use of macrophages to deliver therapeutic and imaging contrast agents to tumors.

Authors:  Jinhyang Choi; Hye-Yeong Kim; Eun Jin Ju; Joohee Jung; Jaesook Park; Hye-Kyung Chung; Jin Seong Lee; Jung Shin Lee; Heon Joo Park; Si Yeol Song; Seong-Yun Jeong; Eun Kyung Choi
Journal:  Biomaterials       Date:  2012-03-06       Impact factor: 12.479

3.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

Authors:  Chunbai He; Yiping Hu; Lichen Yin; Cui Tang; Chunhua Yin
Journal:  Biomaterials       Date:  2010-02-06       Impact factor: 12.479

4.  Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.

Authors:  Arianne M Brandsma; Toine Ten Broeke; Maaike Nederend; Laura A P M Meulenbroek; Geert van Tetering; Saskia Meyer; J H Marco Jansen; M Alejandra Beltrán Buitrago; Sietse Q Nagelkerke; István Németh; Ruud Ubink; Gerard Rouwendal; Stefan Lohse; Thomas Valerius; Jeanette H W Leusen; Peter Boross
Journal:  Cancer Immunol Res       Date:  2015-09-25       Impact factor: 11.151

5.  Cancer incidence increasing globally: The role of relaxed natural selection.

Authors:  Wenpeng You; Maciej Henneberg
Journal:  Evol Appl       Date:  2017-08-24       Impact factor: 5.183

6.  Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner.

Authors:  Daniel W Fowler; John Copier; Angus G Dalgleish; Mark D Bodman-Smith
Journal:  Cancer Immunol Immunother       Date:  2017-05-13       Impact factor: 6.968

Review 7.  Tumor-Associated Macrophages as Target for Antitumor Therapy.

Authors:  Katarzyna Sawa-Wejksza; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-06-28       Impact factor: 4.291

8.  Corrigendum to "New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy".

Authors:  Qiujun Guo; Zhichao Jin; Yuan Yuan; Rui Liu; Tao Xu; Huamin Wei; Xinyao Xu; Shulin He; Shuntai Chen; Zhan Shi; Wei Hou; Baojin Hua
Journal:  J Immunol Res       Date:  2018-07-29       Impact factor: 4.818

9.  Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy.

Authors:  Jiwon Han; Jin Zhen; Van Du Nguyen; Gwangjun Go; Youngjin Choi; Seong Young Ko; Jong-Oh Park; Sukho Park
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

Review 10.  Tumor-associated macrophages: an accomplice in solid tumor progression.

Authors:  Yibing Chen; Yucen Song; Wei Du; Longlong Gong; Haocai Chang; Zhengzhi Zou
Journal:  J Biomed Sci       Date:  2019-10-20       Impact factor: 8.410

View more
  1 in total

1.  Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.

Authors:  Francesco Avolio; Stefano Martinotti; Vladimir Kh Khavinson; Jessica Elisabetta Esposito; Giulia Giambuzzi; Antonio Marino; Ekaterina Mironova; Riccardo Pulcini; Iole Robuffo; Giuseppina Bologna; Pasquale Simeone; Paola Lanuti; Simone Guarnieri; Svetlana Trofimova; Antonio Domenico Procopio; Elena Toniato
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.